Physical Compression Kills Cells via Ferroptosis Triggered by Mitochondrial Collapse
Researchers reveal how mechanical confinement deforms the cell nucleus, fractures mitochondria, and ignites iron-driven cell death—with implications for osteoarthritis.
Summary
When cells are squeezed into tight spaces, the nucleus deforms and triggers a cascade ending in ferroptosis—a regulated, iron-dependent form of cell death. Scientists used microfabricated PDMS pillars and microsphere spacers to confine HeLa and HT1080 cells to 3 µm height, observing that confinement—not hypoxia or nutrient deprivation—caused death. The nucleus acted as a mechanosensor, activating Drp1-driven mitochondrial fragmentation, mitochondrial ROS accumulation, and translocation of cPLA2 to mitochondria. cPLA2 generated arachidonic acid, which combined with mitochondrial ROS to drive lipid peroxidation and ferroptosis. Ferroptosis inhibitors (Ferrostatin-1, Liproxstatin-1, DFOM) significantly rescued cells. Osteoarthritis patient samples showed matching signatures—mitochondrial cPLA2 localization and elevated ROS—linking mechanical overload in disease to this death pathway.
Detailed Summary
Cells in densely packed tissues constantly experience compressive mechanical forces, yet how non-motile or adherent cells respond to prolonged axial confinement at the molecular level was largely unknown. This study, published in Nature Communications, addresses that gap by demonstrating that sustained mechanical confinement triggers ferroptosis—an iron-dependent, regulated form of cell death characterized by lipid peroxidation—through a nucleus-to-mitochondria signaling axis.
The researchers developed two complementary in-vitro confinement platforms: microfabricated PDMS micropillar devices and a stainless-steel weight system with 3 µm microsphere spacers. HeLa cells confined to 3 µm height for 9–12 hours showed progressive, PI-confirmed cell death that was distinct from hypoxia (no HIF1α detection, comparable hypoxia probe signals at 3 µm vs 20 µm), nutrient starvation, pyroptosis (no GSDMD/GSDME cleavage), or necroptosis (no MLKL phosphorylation). Instead, confined cells accumulated total and lipid reactive oxygen species (ROS) within 2 hours, upregulated the ferroptosis biomarker COX-2, and were substantially rescued by ferroptosis inhibitors including Ferrostatin-1, Liproxstatin-1, DFOM, and Trolox.
Mechanistic dissection revealed that the cell nucleus serves as the primary mechanosensor. Confinement caused a 35% increase in nuclear projected surface area. Nuclear deformation—not mechanosensitive ion channels (Piezo) or integrins—drove the downstream response. Specifically, confinement promoted formation of Drp1 liquid-like condensates that associated with mitochondria, driving Drp1-dependent mitochondrial fragmentation. This fragmentation was accompanied by mitochondrial ROS accumulation. Simultaneously, the cytosolic phospholipase A2 (cPLA2) translocated to mitochondria upon confinement, where it generated arachidonic acid (ARA) from mitochondrial phospholipids. The combination of mitochondrial ROS and ARA production concertedly drove lipid peroxidation and ferroptosis execution. Genetic or pharmacological disruption of either Drp1 or cPLA2 attenuated confinement-induced ferroptosis, confirming their orchestrating roles.
Translating these findings to disease, the authors examined osteoarthritis (OA) patient joint tissue—a condition marked by chronic mechanical overloading and inflammation. OA samples displayed characteristic signatures of confinement-induced ferroptosis: mitochondrial localization of cPLA2 and elevated ROS levels, suggesting this mechano-ferroptosis pathway operates in clinically relevant human pathology.
These findings establish a novel mechanobiology paradigm: the nucleus senses axial compression and relays signals through Drp1 and cPLA2 to mitochondria, culminating in ferroptosis. This has broad implications for understanding tissue damage in mechanically stressed environments and may identify new therapeutic targets—particularly Drp1 and cPLA2—for diseases like osteoarthritis where mechanical overload drives pathological cell death.
Key Findings
- 3 µm axial confinement for 9+ hours triggers ferroptosis in HeLa and HT1080 cells, rescued by Ferrostatin-1, Liproxstatin-1, and DFOM.
- The nucleus acts as a mechanosensor; a 35% increase in nuclear surface area upon confinement initiates the death cascade.
- Drp1 condensate formation drives mitochondrial fragmentation and mitochondrial ROS accumulation under mechanical confinement.
- cPLA2 translocates to mitochondria upon confinement, generating arachidonic acid that cooperates with mtROS to cause lipid peroxidation.
- Osteoarthritis patient tissue displays mitochondrial cPLA2 localization and elevated ROS, mirroring the confinement-induced ferroptosis signature.
Methodology
HeLa and HT1080 cells were confined to 3 µm height using PDMS micropillar devices or microsphere-spacer systems for up to 12 hours. Cell death was quantified by PI influx; ferroptosis markers assessed via DHE, BODIPY-C11, COX-2 qRT-PCR, and pharmacological rescue with Ferrostatin-1, Liproxstatin-1, DFOM, and Trolox. Mechanistic pathways were interrogated by genetic knockdown/overexpression of Drp1 and cPLA2, live fluorescence imaging of organelle dynamics, and validation in human osteoarthritis patient samples.
Study Limitations
The study relies primarily on cancer cell lines (HeLa, HT1080), which may not fully represent the behavior of primary non-cancerous adherent cells under confinement. While OA patient tissue shows matching ferroptosis signatures, causal evidence in human disease remains correlational. The precise molecular mechanism linking nuclear deformation to Drp1 condensate formation and cPLA2 mobilization requires further elucidation.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.